Elpiscience Biopharmaceuticals
Research - , Shanghai Shi, China
Elpiscience Biopharmaceuticals Employees
Elpiscience Biopharmaceuticals Details
Elpiscience is a clinical stage biopharmaceutical company focused on innovating and developing next-generation immunotherapy to benefit cancer patients worldwide. The company has a robust pipeline of globally innovative molecules, covering wide range of targets in immuno-oncology. It has four molecules in clinical trials (ES002, ES101, ES102, and ES104), and endeavors to clinically advance at least one innovative molecule a year. Founded and managed by a team of biopharma industry leaders, Elpiscience is backed by renowned investors including, Lilly Asia Ventures, Hillhouse Capital, Hyfinity Investments, Greater Bay Area Homeland Development Fund, CDH, DYEE Capital and Cormorant Asset Management.
Elpiscience Biopharmaceuticals Technologies
Frameworks and Programming Languages
PHP 5.3
Load Balancers
Microsoft-IIS
Other
Mobile Friendly